Founded in 2020 by Alex Federation, PhD, and Lindsay Pino, PhD, Talus Bio is a drug discovery and development company focused on therapeutics that target previously undruggable transcription factors. The Seattle-based company’s proprietary therapeutics discovery platform MARMOT (Multiplexed Assays for the Rational Modulation Of Transcription Factors) integrates next-gen proteomics, synthetic chemistry, AI, and computational biology to engineer and interrogate drugs, proteins, and genomics at unprecedented scale. Talus Bio employs a growing team of more than a dozen world-leading scientific experts in the fields of proteomics, biochemistry, computational biology and machine learning.
